|
Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis |
Liu J, Ma Q, Zhang M, Wang X, Zhang D, Li W, Wang F, Wu E |
|
|
Record Status This is a systematic review that meets the criteria for inclusion on DARE. Bibliographic details Liu J, Ma Q, Zhang M, Wang X, Zhang D, Li W, Wang F, Wu E. Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis. European Journal of Cancer 2012; 48(15): 2328-2338 Indexing Status Subject indexing assigned by NLM MeSH Antibodies, Neoplasm /blood; Biomarkers, Tumor /genetics /metabolism; Carcinoma, Hepatocellular /genetics /immunology /metabolism /pathology; Humans; Liver Neoplasms /genetics /immunology /metabolism /pathology; Prognosis; Survival Analysis; Tumor Suppressor Protein p53 /biosynthesis /genetics /immunology AccessionNumber 12012047464 Date bibliographic record published 14/01/2013 |
|
|
|